- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT03088826
Analgesic Efficacy of (MSIR)/Acetaminophen vs. Oxycodone/Acetaminophen (Percocet)
Comparison of Analgesic Efficacy of Morphine Sulfate Immediate Release (MSIR)/Acetaminophen vs. Oxycodone/Acetaminophen (Percocet) for Acute Pain in Emergency Department Patients
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
The investigators' hypothesis is that MSIR coupled with acetaminophen will have similar if not better analgesic efficacy at 30 minutes and 1 hour than oxycodone coupled with acetaminophen for acute painful conditions in the emergency department.
This study will be a double-blind randomized clinical trial evaluation analgesic efficacy of orally administered MISIR+acetaminophen in comparison to Oxycodone+acetaminophen for treating pain. Patients will be enrolled from a single ED in a tertiary academic center.
Patients based on inclusion criteria will be randomized to receive either 1 tablet of 15mg PO morphine sulfate immediate release combined with 650mg of Acetaminophen or 1 tablet 10mg Oxycodone combined with 650 mg Acetaminophen. All drugs will be crushed and given to the subjects in blinded fashion. Patients, physicians, nurses and research assistants will be blinded to drug assignment throughout the study. Medication will be prepared by on site pharmacist.
Pain will be reassessed at both 30 minutes, 45 minutes and 1 hour with the primary outcome of reduction in pain score by 1.3 points at 60 minutes. Assuming a 1.7 pain difference is minimally significant clinically with standard deviation of 3.0 (based on a previous study of morphine analgesia), a minimum of 50 patients per group will be needed for 80% power with alpha equal to 0.05.
Secondary outcomes will include any reported adverse effects; the requirement of additional analgesia.
Generalized likability and chance of repeated use will be reported by using a visual analogue scale with following questions:
"Do you feel any DRUG EFFECT?" "Do you LIKE the drug?" "How HIGH are you?" "Does the drug have any GOOD EFFECTS?" "Does the drug have any BAD EFFECTS?" "How much do you DESIRE the medication?" " Does the drug make you have UNPLEASANT THOUGHTS?" "Does the drug make you have UNPLEASANT BODILY SENSATIONS?" "Does the drug make you feel IRRITATED?" "Does the drug make it DIFFICULT TO CONCENTRATE?"
The patients will respond by positioning an arrow along a 100-point line labeled with "not at all" at one end and "extremely" at the other.
Data will be analyzed by intention to treat and will include frequency distributions, and Student's T-test to assess a difference in pain scores and vital signs. The chi-square test will assess the presence or absence of side effects between the two groups. Statistical analyses will be conducted by the research manager and the hospital senior biostatistician who will be independent of all data collection.
Study Type
Enrollment (Actual)
Phase
- Phase 2
Contacts and Locations
Study Locations
-
-
New York
-
Brooklyn, New York, United States, 11219
- Maimonides Medical Center
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- ages 18-64,
- present to the Emergency department with moderate-to-severe acute pain that warrants an oral opioid analgesic.
- pain score is above 5 and are deemed to require oral opioid at the discretion of the attending physician.
- Painful conditions will include but will not be limited to acute traumatic/non-traumatic musculoskeletal pain, renal colic pain, dental pain.
Exclusion Criteria:
- age <18, age >64,
- subjects who received long acting opioids within 24 hours of presenting to ED
- received short acting analgesics within 4 hours,
- chronic pain,
- pregnant patients,
- patient refusal,
- altered mental status,
- known allergy to either morphine or oxycodone or acetaminophen,
- history of substance and opioid abuse,
- unstable vital signs, acute psychosis or incarceration.
- subjects who received long acting opioids within 24 hours of presenting to ED;
- chronic pain"
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Quadruple
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Active Comparator: MSIR and Acetaminophen Group
The patients in this group will receive 1 tablet 15mg PO morphine sulfate immediate release combined with 650mg of Acetaminophen
|
15mg PO morphine sulfate
650 mg Acetaminophen
|
Active Comparator: Oxycodone and Acetaminophen Group
The patients in this group will receive 1 tablet 10mg Oxycodone combined with 650mg of Acetaminophen
|
650 mg Acetaminophen
10mg Oxycodone
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Pain Reduction at 60 Minutes (Baseline Pain Score - Pain Score at 60 Minutes)
Time Frame: 60 minutes
|
The reduction of pain at 60 minutes from baseline: The pain scale ranges from 0 to 10 with 0 being no pain, 5 being moderate pain and 10 being very severe pain.
|
60 minutes
|
Collaborators and Investigators
Sponsor
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- 2017-01-05
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Pain Management
-
Assiut UniversityNot yet recruitingPain Management | Neonates Pain Management
-
Wolfson Medical CenterUnknownPain Management | Post Surgical Management | Inflamation ManagementIsrael
-
Sintetica SACross S.A.CompletedPhase 1: Pain Management | Phase 2: Pain ManagementSwitzerland
-
Värmland County Council, SwedenSykehuset Telemark; Örebro University, Sweden; Dalarna County Council, Sweden; Region... and other collaboratorsCompletedInfant Pain Management | Parent-driven Pain ManagementSweden
-
Cedars-Sinai Medical CenterCompletedImmersive Virtual Reality Intervention for Non-Opioid Pain Management: A Randomized Controlled TrialPain | Pain ManagementUnited States
-
VA Office of Research and DevelopmentCompleted
-
Uludag UniversityRecruiting
-
The University of Texas Health Science Center at...Recruiting
-
Carilion ClinicChorda Pharma, Inc.Completed
-
Parkland Health and Hospital SystemCompletedPain ManagementUnited States
Clinical Trials on Morphine Sulfate
-
Roxane LaboratoriesCompleted
-
Brigham and Women's HospitalNational Institute on Drug Abuse (NIDA); Arthritis FoundationCompletedDepression | Anxiety | Degenerative Disc Disease | Chronic Low Back PainUnited States
-
University of Alabama at BirminghamActive, not recruiting
-
Assiut UniversityCompleted
-
Stanford UniversityTerminated
-
MedtronicNeuroTerminated
-
Indiana UniversityCompletedNeonatal Abstinence Syndrome | Neonatal Opioid Withdrawal Syndrome | Neonatal Opioid WithdrawalUnited States
-
QRxPharma Inc.Completed
-
Xuanhan County People's HospitalCompletedAnalgesia | Gynecological; Surgery (Previous), Affecting Fetus or Newborn, Due to Obstructed LaborChina
-
Actavis Inc.Completed